Philanthropy & Grantmaking
(T50Z)
IRS Verified
DX Registered
990 on File
ROFEH CHOLIM CANCER SOCIETY INC
Financial strength (30%)
75/100
Reliability (20%)
55/100
Effectiveness (25%)
78/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
The organization has been established to help ease the suffering of cancer patients and their families by providing financial subsidies, patient advocacy services, emotional and psychosocial support, assistance in obtaining medical treatment, and education on prevention, detection and treatment of cancer.
Financial Overview — FY 2024
$24.0M
Total Revenue
$25.4M
Total Expenses
$25.5M
Net Assets
78
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
70.0%
Fundraising Efficiency
N/A
Operating Reserve
12.03x
Liability-to-Asset
4.3%
Revenue Diversification
121.3%
Executive Compensation
$1000K
Compared with Peers
FY 2024
Compared with 923 similar organizations
(United States, Philanthropy & Grantmaking, $10M–$100M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
70.0% | 91.7% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
10.0% | 6.2% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
20.0% | 2.2% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
12.0 mo | 70.2 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
4.3% | 2.5% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
121.3% | 88.2% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
-12.0% | 17.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-4.5% | 10.6% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-6.2% | 6.3% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $24.0M | $25.4M | $25.5M | 70.0% | 78 |
| 2023 | $27.2M | $26.6M | $27.2M | 64.9% | 74 |
| 2022 | $25.4M | $20.7M | $27.1M | 63.2% | 70 |
| 2021 | $22.7M | $14.3M | N/A | — | 57 |
| 2020 | $14.0M | $10.5M | N/A | — | 51 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.